Key Points
The initial share sale of Mankind Pharma was subscribed 32% on Day 2 with non-institutional investors (NIIs) and qualified institutional buyers (QIB) doing the heavy lifting..
Ahead of its IPO, Mankind Pharma has raised around Rs 1,297 crore by allocating 1.2 crore equity shares to 77 anchor investors...
Some of the marquee foreign and domestic institutions including Goldman Sachs, Canada Pension Plan, Government of Singapore, Fidelity Investment Trust among others participated in the anchor round, which was done at a price of Rs 1,080 per share...
Mankind Pharma is the fourth-largest Indian pharmaceutical company in terms of domestic sales and third largest in terms of sales volume for moving annual total as of December 2022...
At the higher end of the price band, the shares of Mankind Pharma are valued at 30x FY22 EPS..
You might be interested in
Ideaforge IPO: GMP soars nearly 80% as issue gets fully subscribed. Here's what brokerages say
26, Jun, 23The NII part was subscribed 1.89 times so far, while there were no bids from qualified institutional buyers. According to market sources, the company's shares are commanding a premium of Rs 525-530 in the unlisted market, indicating big listing gains for investors if the trends sustain.
Mankind Pharma IPO to hit market next week. Here are 10 key factors of the offer
20, Apr, 23Mankind IPO will be entirely offer for sale and its proposed equity shares will list on BSE and NSE. The pharma major expects the listing of its equity shares to enhance its visibility and brand, while also providing liquidity to its existing shareholders.
Mankind Pharma raises Rs 1,297 crore from anchor investors ahead of IPO
24, Apr, 23The anchor allocation was done at Rs 1,080 per share, under which Goldman Sachs, Canada Pension Plan, Government of Singapore, and Fidelity Investment Trust, among others, have participated.
Sachin Tendulkar-backed Azad Engineering raises Rs 221 crore from 20 anchor investors on IPO eve
19, Dec, 23India Business News: Cricketing legend Sachin Tendulkar-backed Azad Engineering has raised Rs 221 crore from anchor investors on the eve of its Rs 740-crore IPO. The IPO,
Ahead of IPO, Mankind Pharma mobilizes Rs 1,298 crore from anchor investors
24, Apr, 23India Business News: Mankind Pharma on Monday said it has raised Rs 1,298 crore from anchor investors ahead of its initial share sale that opens for subscription on April
Mankind Pharma IPO opens for subscription today: Should you bid?
25, Apr, 23The issue opens for subscription today and will be available for the public to bid till April 27. Investors can bid for 13 shares in one lot and in multiples thereof. The price band is set at Rs 1,026-1,080 per share.
Mankind Pharma Block Deal: Chrys Capital divests stake worth ₹3,200 crore, Beige sells 1.44 crore shares
12, Dec, 23Kotak Mutual Funds acquired 2 million shares in the pharmaceutical company at a price of ₹1,832.30 per share.
India Shelter Finance raises ₹360 crore from anchor investors ahead of IPO
13, Dec, 23As many as 38 investors participated in the anchor book, including ICICI Prudential, Goldman Sachs, and Massachusetts Institute of Technology.
Avalon Technologies shares tumble 11% on listing day. Should you hold or sell?
18, Apr, 23The stock is currently trading nearly 8% down at Rs 396.90 on BSE. It hit the day's low of Rs 387.75, translating into a fall of 11% from IPO price. The tepid listing was expected after the downtrend in company shares in the unlisted market since the IPO opened for subscription. The issue was subscribed 2.21 times at close